RPSA
Richard P. Slaughter Associates’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,901
| Closed | -$1.26M | – | 152 |
|
|
2024
Q3 | $1.26M | Sell |
18,901
-4,817
| -20% | -$322K | 0.29% | 86 |
|
|
2024
Q2 | $2.82M | Sell |
23,718
-730
| -3% | -$86.7K | 0.66% | 35 |
|
|
2024
Q1 | $2.61M | Sell |
24,448
-5,555
| -19% | -$592K | 0.62% | 41 |
|
|
2023
Q4 | $2.98M | Buy |
30,003
+10,036
| +50% | +$998K | 0.74% | 26 |
|
|
2023
Q3 | $2.06M | Buy |
19,967
+3,962
| +25% | +$409K | 0.55% | 44 |
|
|
2023
Q2 | $1.94M | Buy |
16,005
+276
| +2% | +$33.5K | 0.56% | 50 |
|
|
2023
Q1 | $2.42M | Sell |
15,729
-197
| -1% | -$30.3K | 0.79% | 30 |
|
|
2022
Q4 | $2.86M | Sell |
15,926
-23
| -0.1% | -$4.13K | 0.9% | 31 |
|
|
2022
Q3 | $1.89M | Buy |
15,949
+1,934
| +14% | +$229K | 0.79% | 40 |
|
|
2022
Q2 | $2M | Buy |
14,015
+133
| +1% | +$19K | 0.88% | 30 |
|
|
2022
Q1 | $2.39M | Buy |
13,882
+3,192
| +30% | +$550K | 0.88% | 35 |
|
|
2021
Q4 | $2.72M | Buy |
10,690
+5,656
| +112% | +$1.44M | 0.96% | 32 |
|
|
2021
Q3 | $1.94M | Sell |
5,034
-9,034
| -64% | -$3.48M | 0.77% | 43 |
|
|
2021
Q2 | $3.31M | Buy |
+14,068
| New | +$3.31M | 1.28% | 19 |
|